Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122568567 | 12256856 | 7 | F | 201603 | 20160822 | 20160412 | 20160825 | EXP | JP-GLAXOSMITHKLINE-JP2016JPN047152 | GLAXOSMITHKLINE | 70.00 | YR | F | Y | 50.00000 | KG | 20160825 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122568567 | 12256856 | 1 | PS | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 1000 MG, TID | Y | 20487 | 1000 | MG | TABLET | TID | |||||
122568567 | 12256856 | 2 | SS | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 1000 MG, BID | Y | 20487 | 1000 | MG | TABLET | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122568567 | 12256856 | 1 | Herpes zoster |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122568567 | 12256856 | OT |
122568567 | 12256856 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122568567 | 12256856 | Decreased appetite | |
122568567 | 12256856 | Headache | |
122568567 | 12256856 | Malaise | |
122568567 | 12256856 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122568567 | 12256856 | 1 | 20160325 | 20160325 | 0 | |
122568567 | 12256856 | 2 | 20160326 | 20160328 | 0 |